Literature DB >> 8377234

Saphenous vein biopsy: a predictor of vein graft failure.

M L Marin1, F J Veith, T F Panetta, R E Gordon, K R Wengerter, W D Suggs, L Sanchez, M K Parides.   

Abstract

PURPOSE: To determine why some vein grafts fail, we prospectively studied the relationship between the histologic condition of the greater saphenous vein (GSV) at the time of grafting and subsequent stenosis of the vein graft.
METHODS: Ninety-four remnant segments of GSVs were obtained at the time of infrainguinal bypass in 91 patients and were perfusion fixed before histologic and ultrastructural examination. All bypass grafts were evaluated clinically and by duplex ultrasonography at regular intervals from 1 to 30 months after operation. All 24 grafts that developed lesions that caused thrombosis (failed grafts) or flow reduction (failing grafts) underwent arteriography and appropriate operative or other interventional correction of the causative lesion.
RESULTS: There was no significant difference in the incidence of coronary artery disease, kidney disease, hypertension, or history of smoking in patients with normally functioning and failed or failing grafts. Diabetes occurred with an increased frequency in failed or failing grafts (p = 0.056). At the time of their insertion, GSVs that subsequently developed significant lesions had thicker walls (0.72 +/- 0.33 mm) compared with normally functioning grafts (0.58 +/- 21 mm; p < 0.02). Most of this difference was related to a significantly thicker intima (0.27 +/- 0.17 vs 0.11 +/- 0.7 mm; p < 0.0001). Another significant finding was the presence of subendothelial spindle-shaped cells greater than five cell layers thick. This occurred more often in pregraft biopsies from grafts that developed significant lesions (70.4% vs 7.5%, p < 0.0001). Electron microscopic examination of these cells demonstrated a subpopulation of poorly differentiated cells with few fibers and many vesicles. Four of 24 (17%) failed or failing grafts had evidence of vein wall calcification at the time of vein grafting. This was seen in only one (1.4%) of 70 normally functioning grafts without lesions (p < 0.005).
CONCLUSIONS: We conclude that GSVs with thick and calcified walls or hypercellular intima at the time of grafting are at increased risk of developing intragraft lesions that may lead to graft failure. Frequent duplex ultrasonography surveillance is particularly warranted for such high-risk grafts.

Entities:  

Mesh:

Year:  1993        PMID: 8377234

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Perioperative use of eicosapentaenoic acid and patency of infrainguinal vein bypass: A retrospective chart review.

Authors:  Shinsuke Mii; Terutoshi Yamaoka; Daihiko Eguchi; Jin Okazaki; Kiyoshi Tanaka
Journal:  Curr Ther Res Clin Exp       Date:  2007-05

Review 2.  Vein quality in infrainguinal revascularisation: assessment by angioscopy and histology.

Authors:  Y G Wilson
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

3.  Vein factors that affect the outcome of femorodistal bypass.

Authors:  A H Davies
Journal:  Ann R Coll Surg Engl       Date:  1995-01       Impact factor: 1.891

4.  Clinical factors that influence the cellular responses of saphenous veins used for arterial bypass.

Authors:  Michael Sobel; Shinsuke Kikuchi; Lihua Chen; Gale L Tang; Tom N Wight; Richard D Kenagy
Journal:  J Vasc Surg       Date:  2018-06-15       Impact factor: 4.268

5.  Calcification of Human Saphenous Vein Associated with Endothelial Dysfunction: A Pilot Histopathophysiological and Demographical Study.

Authors:  Sydney L Pedigo; Christy M Guth; Kyle M Hocking; Alex Banathy; Fan Dong Li; Joyce Cheung-Flynn; Colleen M Brophy; Raul J Guzman; Padmini Komalavilas
Journal:  Front Surg       Date:  2017-02-09

Review 6.  Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction.

Authors:  Bohan Chen; Pei Wang; Andrew Brem; Lance Dworkin; Zhangsuo Liu; Rujun Gong
Journal:  EBioMedicine       Date:  2018-12-05       Impact factor: 8.143

7.  Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts.

Authors:  Ute Reisinger; Stefan Schwaiger; Iris Zeller; Barbara Messner; Robert Stigler; Dominik Wiedemann; Tobias Mayr; Christoph Seger; Thomas Schachner; Verena M Dirsch; Angelika M Vollmar; Johannes O Bonatti; Hermann Stuppner; Günther Laufer; David Bernhard
Journal:  Cardiovasc Res       Date:  2009-02-19       Impact factor: 10.787

8.  Predictive factors of late venous aortocoronary graft failure: ultrastructural studies.

Authors:  Bartlomiej Perek; Agnieszka Malinska; Sebastian Stefaniak; Danuta Ostalska-Nowicka; Marcin Misterski; Maciej Zabel; Anuj Suri; Michal Nowicki
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.